Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib;Kutane Nebenwirkungen der Multikinaseinhibitoren Sorafenib und Sunitinib

Hautarzt

Volumn 61, Issue 8, 2010, Pages 662-667

  Wollenberg, A ^a   Staehler, M ^a   Eames, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cutaneous side effects; Hand foot syndrome; Sorafenib; Sunitinib; Targeted therapy

Indexed keywords

CELECOXIB; CLOBETASOL; CYTARABINE; DEXAMETHASONE; PYRIDOXINE; SORAFENIB; SUNITINIB;

ANTINEOPLASTIC ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TOLERABILITY; HAND FOOT SYNDROME; HUMAN; MACULOPAPULAR RASH; MOLECULARLY TARGETED THERAPY; REVIEW; SKIN MANIFESTATION; VASOCONSTRICTION;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; DRUG DELIVERY SYSTEMS; DRUG ERUPTIONS; HUMANS; INDOLES; NEOPLASMS; PROTEIN KINASE INHIBITORS; PYRIDINES; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956344862     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-010-1942-7     Document Type: Review

References (10)

1. Strumberg D, Awada A, Hirte H et al (2006) Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? Eur J Cancer 42:548-556
2. Ivanyi P, Winkler T, Ganser A et al (2008) Novel therapies in advanced renal cell carcinoma: management of adverse events from sorafenib and sunitinib. Dtsch Arztebl Int 105:232-237
3. Lombardi G, Zustovich F, Donach M et al (2010) An update on targeted therapy in metastatic renal cell carcinoma. Urol Oncol [Epub ahead of print]
4. Kähler KC, Hauschild A (2010) Hautveränderungen durch .,targeted therapies" bei onkologischen Patienten: Kutane Nebenwirkungen zielgerichteter Therapie bei onkologischen Patienten. Hautarzt 60(5):433-440
5. Pföhler C, Ugurel S (2008) Kutane Nebenwirkungen molekularer zielgerichteter Therapien. Hautarzt 59(10):814-820
6. Lipworth AD, Robert C, Zhu AX (2009) Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology 77(5):257-271
7. Staehler M, Haseke N, Schöppler G et al (2006) Antiiangiogenetische Therapie beim Nierenzellkarzinom. Urologe 45:1333-1344
8. Rote Liste 2010 - Arzneimittelverzeichnis für Deutschland (2010) Rote Liste Service GmbH, Frankfurt/Main
9. Lee WJ, Lee JL, Chang SE, Lee MW et al (2009) Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Br J Dermatol 161:1045-1051
10. Holtmann MH, Siepmann U, Mahlkow S et al (2009) Gastroenterologische Symptomenkontrolle in der Palliativmedizin (Teil 1). Z Gastroenterol 46:712-724